By Linda on Nov 10, 2010 in Infections | comments(0)
Full article: http://betterhealthguy.com/joomla/blog/216-ilads-2010-conference-takeaways
Excerpt:
In October 2010, I attended the ILADS 2010 Annual event. The event was packed. Almost 400 people attended in person and over 1,000 people watched on the live webcast. It is exciting to see so many people taking an interest in this controversial area of medicine. The event was full of great information and people working hard to help us all find answers.
In this blog entry, I will share a few of the key takeaways that I learned at the event. The slides from the event are available for purchase here for a very reasonable $40. The DVDs (Friday’s sessions) and CDs of the presentations can be obtained from ZenWorks Productions. Thus, I am not going to attempt to repeat information that is available elsewhere, but I will focus on some of the key things that caught my attention.
- The 2011 ILADS event will be in Toronto, Canada – October 28-30, 2011
- Dr. Richard Horowitz proposed that Chronic Lyme is really MCIDS – MultipleChronic Infectious Disease Syndrome
- Biofilm treatment may be with EDTA or a Banderol/Samento combination. There may be a strong antigen release with biofilm treatment which may make it a good candidate for pulsed therapy
- Dr. Steve Harris mentioned that yeast may cannibalize dying Borrelia and that yeast is not always the result of antibiotic therapy alone. He suggested up to 100 billion probiotic organisms daily. In terms of diet, he said, “If it’s white, it ain’t right”
- Minocycline may have longer toxic effects than doxycycline but has better CNS penetration. Mino also has less sun sensitivity than doxy. That said, Dr. Joe Burrascano commented that the effectiveness of minocycline may be regional as he never observed it working well in his patients
By Linda on Jul 28, 2010 in Infections | comments(0)
Full article: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=20621802&retmode=ref&cmd=prlinks
Excerpt:
Lyme optic neuritis (ON) is a rare disease and only a few cases
have been reported. We describe two cases of isolated Lyme ON,
one with recurrence 9 months after the appearance of initial
symptoms. Diagnosis criteria for multiple sclerosis and
neuromyelitis optica were not met. The etiological diagnosis was
based on European case definition criteria for neuroborreliosis.
Both patients had positive serum and cerebrospinal fluid
serology, a positive intrathecal anti-Borrelia antibody index,
and a good outcome on ceftriaxone. Specific diagnosis of Lyme ON
is important since improvement of visual acuity is possible with
specific antibiotherapy, even after many months. Copyright (c)
2010 Elsevier B.V. All rights reserved.
By Linda on Apr 21, 2010 in Infections | comments(0)
Excerpt:
Although intravenous antibiotic therapy is recommended for
neurologic Lyme disease, safety concerns have been raised about
treatment beyond 30 days in patients with persistent neurologic
symptoms. The goal of our study was to evaluate the safety of
extended intravenous antibiotic therapy in patients referred for
treatment of neurologic Lyme disease.
METHODS: We enrolled 200
consecutive patients with significant neurologic symptoms and
positive testing for Borrelia burgdorferi. Patients were treated
with intravenous antibiotics using various intravascular devices
(IVDs). Standard IVD care was administered to all patients, and
monitoring for medication reactions and IVD complications was
performed on a weekly basis.
RESULTS: The mean length of intravenous
antibiotic treatment was 118 days (range, 7-750 days)
representing 23,654 IVD-days. Seven patients (3.5%) experienced
allergic reactions to the antibiotic medication, and two patients
(1.0%) had gallbladder toxicity. IVD complications occurred in 15
patients (7.5%) representing an incidence of 0.63 per 1,000
IVD-days. The IVD problems occurred an average of 81 days after
initiation of treatment (range, 7-240 days). There were six
suspected line infections for an incidence of 0.25 per 1,000
IVD-days. Only one of the IVD infections was confirmed, and no
resistant organisms were cultured from any patient. None of the
IVD complications were fatal.
CONCLUSION: Prolonged intravenous antibiotic therapy is
associated with low morbidity and no IVD-related mortality in
patients referred for treatment of neurologic Lyme disease. With
proper IVD care, the risk of extended antibiotic therapy in these
patients appears to be low.
By Linda on Mar 13, 2010 in Infections | comments(0)
Linda’s comments: Lyme Carditis in children is not getting the attention it should be getting. Makes me wonder how many of the athletes who drop dead in their sport isn’t suffering from Lyme Carditis and have been grossly mis-diagnosed??
For those with children with Lyme disease, please read this carefully. Listen to symptoms and don’t ignore what perhaps a conventional has mis-diagnosed. Reducing our children’s total body of burden and pathogens is something that parents have to take control of. It is more critical in teens, who most of the time will not listen….It will help you to lessen your fears (that we all know most teens have a terrible diet) by getting them on a detox protocol with healthy support of their bodies.
Regards,
Linda or Angel
Excerpt:
NEW YORK (Reuters Health) May 01 – Manifestations of Lyme carditis in children can range from asymptomatic first-degree heart block to fulminant myocarditis, physicians at Harvard Medical School report in the May issue of Pediatrics. Data from their case series indicate that older age, arthralgia, and cardiopulmonary symptoms were independent predictors of carditis in pediatric patients with early disseminated Lyme disease. Continued
